ESPR logo

ESPR
Esperion Therapeutics Inc.

9,206
Mkt Cap
$808.25M
Volume
7.43M
52W High
$4.18
52W Low
$0.6925
PE Ratio
-14.99
ESPR Fundamentals
Price
$3.14
Prev Close
$3.14
Open
$3.14
50D MA
$2.53
Beta
1.53
Avg. Volume
7.79M
EPS (Annual)
-$0.1091
P/B
-2.55
Rev/Employee
$1.37M
$1,149.25
Loading...
Loading...
News
all
press releases
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH PR Newswire NEW YORK, May 6, 2026 NEW YORK, May 6, 2026 /PRNewswire/ -- Class...
PR Newswire·3d ago
News Placeholder
More News
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Receives "Hold" Rating from Needham & Company LLC
Needham & Company LLC reissued a 'hold' rating on shares of Esperion Therapeutics in a research report on Monday...
MarketBeat·5d ago
News Placeholder
Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders?
Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders? Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 4, 2026 Insiders may stand to...
PR Newswire·5d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Sees Large Volume Increase - What's Next?
Esperion Therapeutics (NASDAQ:ESPR) Sees Large Volume Increase - Should You Buy...
MarketBeat·5d ago
News Placeholder
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Esperion Therapeutics, Inc. (NasdaqGM: ESPR) to...
Business Wire·5d ago
News Placeholder
What's Going On With Esperion Therapeutics Stock On Monday?
Esperion rises on ARCHIMED's $1.1 billion buyout with $3.16 cash per share and CVR-linked milestones tied to future U.S. sales performance.read more...
Benzinga·5d ago
News Placeholder
Promising Penny Stocks To Watch Today - May 3rd
Esperion Therapeutics, SOBR Safe, JetBlue Airways, BigBear.ai, Lakewood-Amedex Biotherapeutics, Beyond Meat, and Direxion Daily AMD Bear 1X Shares are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small public companiesc...
MarketBeat·6d ago
News Placeholder
Small Cap Stocks To Follow Now - May 2nd
Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, Cue Biopharma, Esperion Therapeutics, and Akanda are the five Small Cap stocks to watch today, according to MarketBeat's stock...
MarketBeat·7d ago
News Placeholder
Penny Stocks To Watch Today - May 2nd
Esperion Therapeutics, SOBR Safe, JetBlue Airways, BigBear.ai, Lakewood-Amedex Biotherapeutics, Beyond Meat, and Direxion Daily AMD Bear 1X Shares are the seven Penny stocks to watch today, according...
MarketBeat·7d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Downgraded by Cantor Fitzgerald to "Hold"
Cantor Fitzgerald lowered shares of Esperion Therapeutics from a "strong-buy" rating to a "hold" rating in a research report on Friday...
MarketBeat·7d ago
<
1
2
...
>

Latest ESPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.